-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation